- AU$88.60m
- AU$76.02m
- AU$91.68m
- 79
- 69
- 70
- 82
Annual balance sheet for SomnoMed, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 30.2 | 21.1 | 15.6 | 12 | 16.2 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6.13 | 8.22 | 9.2 | 9.03 | 8.24 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 40.2 | 34.1 | 30.3 | 27.5 | 35.1 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 10.2 | 10.3 | 9.12 | 12.7 | 11.1 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 61.7 | 56.2 | 58.1 | 62.5 | 69.8 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 18.8 | 16.2 | 23.8 | 18.4 | 19.9 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 27.9 | 24 | 30.3 | 40.1 | 24.8 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 33.8 | 32.2 | 27.8 | 22.4 | 45 |
Total Liabilities & Shareholders' Equity | 61.7 | 56.2 | 58.1 | 62.5 | 69.8 |
Total Common Shares Outstanding |